SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.68 |
| Enterprise Value ($M) | 6.03 |
| Book Value ($M) | 3.12 |
| Book Value / Share | 0.31 |
| Price / Book | 0.86 |
| NCAV ($M) | -6.85 |
| NCAV / Share | -0.68 |
| Price / NCAV | -0.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.45 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -0.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.61 |
| Current Ratio | 0.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.72 |
| Assets | 20.69 |
| Liabilities | 17.58 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ayrton Capital LLC | 6.50 | 175.45 | |
| 13G/A | Intracoastal Capital, Llc | 4.99 | 226.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 18,792 | 75,697 | 24.83 | |
| 49,689 | 147,349 | 33.72 | |
| 143,094 | 310,416 | 46.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRQR – ProQR Therapeutics N.V. | PRTG – Portage Biotech Inc. |
| PTIX – Protagenic Therapeutics, Inc. | PULM – Pulmatrix, Inc. |
| QLGN – Qualigen Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io